COVID-19, caused by the SARS-CoV-2 virus, has revealed a complex interplay between
inflammation and coagulation, leading to the emergence of the concept of thrombo …

Coronavirus infectious disease-19 (COVID-19) is a pandemic characterized by serious lung
disease and thrombotic events in the venous and circulation trees, which represent a …

An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …

Purpose of Review COVID-19 has rapidly evolved into a global pandemic infecting over two
hundred and forty-four million individuals to date. In addition to the respiratory sequelae and …

COVID-19 is a new pandemic, caused by Severe Acute Respiratory Syndrome-CoronaVirus-
2 (SARS-Cov2) infection and characterized by a broad spectrum of clinical manifestations …

The cardinal pathology of coronavirus disease 2019 (COVID-19) is a primary infection of
pulmonary tract cells by severe acute respiratory syndrome coronavirus 2, provoking a local …

Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-
19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical …

The global pandemic Coronavirus disease 2019 (COVID-19) is caused by a novel highly
virulent beta-coronavirus SARS-CoV-2. The infection SARS-CoV-2 is associated with a …

Background: Thrombosis plays a crucial role in the morbidity and mortality of coronavirus
disease-19 (COVID-19). About one-third of COVID-19 patients experience a thrombotic …

Thrombotic complications of the novel coronavirus (COVID-19) are a concerning aspect of
the disease, due to the high incidence in critically ill patients and poor clinical outcomes …